Methyl 4-bromo-5-cyano-3-methylthiophene-2-carboxylate, 95.0%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methyl-4-phenylpentanoic acid, 97%, 1g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-acetamide, 95.0%, 5g

2-Acetylcyclohexanone>97.0%(GC)10mL

Orotic acid, min. 99%, anhydrous, 100 g, plastic packaging.

3-(N-tert-Butoxycarbonyl-N-methylamino)aniline, 95.0%, 1g

(3-Chloro-4-cyanophenyl)boronic acid, 95.0%, 1g

alpha,alpha'-Dibromo-p-xylene>98.0%(GC)25g

4-[(4-methoxyphenyl)sulfonyl]piperidine hydrochloride, 95.0%, 1g

(1S,2S)-(-)-1,2-DIAMINOCYCLOHEXANE-N,N'-BIS(2'-DIPHENYLPHOSPHINOBENZOYL), 97%, 25g

Glutaraldehyde 50 %, 2.5 l

(2E)-1-(2,5-dichlorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

tert-Butyl 4-oxo-3-azatricyclo[4.2.1.02,5]non-7-ene-3-carboxylate, 95%, 5g